Reported Q: Q3 2025 Rev YoY: -20.2% EPS YoY: -474.7% Move: 0.00%
Precision Optics
PEYE
$1.950 0.00%
Exchange OTC Sector Healthcare Industry Medical Instruments Supplies
Q3 2025
Published: May 15, 2025

Company Status Snapshot

Fast view of the latest quarter outcome for PEYE

Reported

Report Date

May 15, 2025

Quarter Q3 2025

Revenue

4.19M

YoY: -20.2%

EPS

-0.30

YoY: -474.7%

Market Move

0.00%

Previous quarter: Q2 2025

Follow this company to get upcoming quarter alerts automatically.

Earnings Highlights

  • Revenue of $4.19M down 20.2% year-over-year
  • EPS of $-0.30 decreased by 474.7% from previous year
  • Gross margin of 10.0%
  • Net income of -2.10M
  • "No earnings call transcript available for QQ3 2025." -
PEYE
Company PEYE

Executive Summary

Precision Optics Corporation Inc (PEYE) reported QQ3 2025 results characterized by a material top-line decline and pronounced margin compression, culminating in a meaningful net loss. Revenue of $4.186 million declined 7.5% QoQ and 20.15% YoY, while gross profit was $0.418 million on a 9.99% gross margin, signaling limited pricing power and potential underutilization of fixed cost absorption. Operating income stood at $(2.038) million with an EBITDAR of $(2.039) million, translating to an operating margin of approximately -48.7% and an EBITDA loss. The net loss was $(2.097) million or $(0.30) per share, underscoring persistent profitability challenges despite a smaller quarterly base. On the balance sheet, liquidity remains adequate on a working-capital basis, with a current ratio near 2.0, cash of $2.548 million, and total debt of $0.670 million. However, the company funded a substantial portion of the quarter through equity issuance, with common stock totaling $3.861 million issued, suggesting reliance on external financing to sustain operations. Free cash flow remained negative at $(1.997) million, driven by negative operating cash flow of $(1.873) million despite modest capex of $(0.125) million. Management commentary is not included in the provided transcript; thus, the assessment relies on disclosed financials and industry context. The near-term outlook hinges on stabilization or growth in revenue, scaling of high-margin components, and the ability to reduce operating and SG&A costs while maintaining prudent liquidity management.

Key Performance Indicators

Revenue
Decreasing
4.19M
QoQ: -7.53% | YoY: -20.15%
Gross Profit
Decreasing
417.98K
9.99% margin
QoQ: -60.93% | YoY: -77.51%
Operating Income
Decreasing
-2.04M
QoQ: -123.98% | YoY: -688.42%
Net Income
Decreasing
-2.10M
QoQ: -116.23% | YoY: -561.32%
EPS
Decreasing
-0.30
QoQ: -100.00% | YoY: -474.71%

Revenue Trend

Margin Analysis

Historical Earnings Comparison

PeriodRevenue ($M)EPS ($)YoY GrowthReport
Q3 2025 4.19 -0.30 -20.2% View
Q2 2025 4.53 -0.15 -9.9% View
Q1 2025 4.20 -0.21 -13.0% View
Q4 2024 4.72 -0.23 +9.1% View
Q3 2024 5.24 -0.05 +3.9% View